Skip to content
Home/Companies/Healthcare/Orthalis
Orthalis

Orthalis

Healthcare·France·Exited 2026·Held 4yr
Entry
2022
Hold
4yr
Exit
2026

Who owns Orthalis?

Orthalis was owned by Extens through Extens III (2022 vintage) from 2022 to 2026, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Extens
Investor
Extens
Extens III · 2022 · Growth

Key facts

HQFrance
SectorHealthcare
Websitewww.orthalis.com
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2026

More from Extens III

Other portfolio companies in the same fund.

SignalSoft Développement
Active
HealthcareFrance· 2026
Medicore
Medicore
Active
HealthcareNetherlands· 2024
Imagine Human
Active
SoftwareFrance· 2023
Val Solutions
Val Solutions
Active
HealthcareFrance· 2023
Canal Santé
Active
HealthcareFrance· 2022
Medelse
Active
HealthcareFrance· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Orthalis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Orthalis?

4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Orthalis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue